Article (Périodiques scientifiques)
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions.
Tiane, Assia; Schepers, Melissa; Reijnders, Rick A. et al.
2023In Acta Neuropathologica
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
s00401-023-02596-8.pdf
Postprint Éditeur (4.13 MB)
Télécharger

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
Epigenetic editing; Epigenetics; Oligodendrocyte; Progressive MS
Résumé :
[en] In the progressive phase of multiple sclerosis (MS), the hampered differentiation capacity of oligodendrocyte precursor cells (OPCs) eventually results in remyelination failure. We have previously shown that DNA methylation of Id2/Id4 is highly involved in OPC differentiation and remyelination. In this study, we took an unbiased approach by determining genome-wide DNA methylation patterns within chronically demyelinated MS lesions and investigated how certain epigenetic signatures relate to OPC differentiation capacity. We compared genome-wide DNA methylation and transcriptional profiles between chronically demyelinated MS lesions and matched normal-appearing white matter (NAWM), making use of post-mortem brain tissue (n = 9/group). DNA methylation differences that inversely correlated with mRNA expression of their corresponding genes were validated for their cell-type specificity in laser-captured OPCs using pyrosequencing. The CRISPR-dCas9-DNMT3a/TET1 system was used to epigenetically edit human-iPSC-derived oligodendrocytes to assess the effect on cellular differentiation. Our data show hypermethylation of CpGs within genes that cluster in gene ontologies related to myelination and axon ensheathment. Cell type-specific validation indicates a region-dependent hypermethylation of MBP, encoding for myelin basic protein, in OPCs obtained from white matter lesions compared to NAWM-derived OPCs. By altering the DNA methylation state of specific CpGs within the promotor region of MBP, using epigenetic editing, we show that cellular differentiation and myelination can be bidirectionally manipulated using the CRISPR-dCas9-DNMT3a/TET1 system in vitro. Our data indicate that OPCs within chronically demyelinated MS lesions acquire an inhibitory phenotype, which translates into hypermethylation of crucial myelination-related genes. Altering the epigenetic status of MBP can restore the differentiation capacity of OPCs and possibly boost (re)myelination.
Disciplines :
Biochimie, biophysique & biologie moléculaire
Auteur, co-auteur :
Tiane, Assia
Schepers, Melissa
Reijnders, Rick A.
van Veggel, Lieve
Chenine, Sarah
Rombaut, Ben
Dempster, Emma
Verfaillie, Catherine
Wasner, Kobi
GRÜNEWALD, Anne  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Molecular and Functional Neurobiology
Prickaerts, Jos
Pishva, Ehsan
Hellings, Niels
van den Hove, Daniel
Vanmierlo, Tim
Plus d'auteurs (5 en +) Voir moins
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions.
Date de publication/diffusion :
2023
Titre du périodique :
Acta Neuropathologica
ISSN :
0001-6322
eISSN :
1432-0533
Maison d'édition :
Springer, Allemagne
Peer reviewed :
Peer reviewed vérifié par ORBi
Projet FnR :
FNR9631103 - Modelling Idiopathic Parkinson'S Disease-associated Somatic Variation In Dopaminergic Neurons, 2015 (01/01/2016-31/12/2022) - Anne Grünewald
Commentaire :
© 2023. The Author(s).
Disponible sur ORBilu :
depuis le 08 juin 2023

Statistiques


Nombre de vues
112 (dont 1 Unilu)
Nombre de téléchargements
85 (dont 0 Unilu)

citations Scopus®
 
17
citations Scopus®
sans auto-citations
13
citations OpenAlex
 
21
citations WoS
 
16

Bibliographie


Publications similaires



Contacter ORBilu